annual FCF:
$6.35B+$1.29B(+25.54%)Summary
- As of today (April 18, 2025), ABT annual free cash flow is $6.35 billion, with the most recent change of +$1.29 billion (+25.54%) on December 31, 2024.
- During the last 3 years, ABT annual FCF has fallen by -$2.30 billion (-26.56%).
- ABT annual FCF is now -26.56% below its all-time high of $8.65 billion, reached on December 31, 2021.
Performance
ABT Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
$2.15B-$1.00M(-0.05%)Summary
- As of today (April 18, 2025), ABT quarterly free cash flow is $2.15 billion, with the most recent change of -$1.00 million (-0.05%) on December 31, 2024.
- Over the past year, ABT quarterly FCF has dropped by -$135.00 million (-5.91%).
- ABT quarterly FCF is now -31.13% below its all-time high of $3.12 billion, reached on December 31, 2020.
Performance
ABT quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$6.35B-$135.00M(-2.08%)Summary
- As of today (April 18, 2025), ABT TTM free cash flow is $6.35 billion, with the most recent change of -$135.00 million (-2.08%) on December 31, 2024.
- Over the past year, ABT TTM FCF has increased by +$1.29 billion (+25.54%).
- ABT TTM FCF is now -31.81% below its all-time high of $9.31 billion, reached on September 30, 2021.
Performance
ABT TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
ABT Free cash flow Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +25.5% | -5.9% | +25.5% |
3 y3 years | -26.6% | -5.9% | +25.5% |
5 y5 years | +41.2% | -5.9% | +25.5% |
ABT Free cash flow Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -26.6% | +25.5% | -7.1% | +242.6% | -25.6% | +41.4% |
5 y | 5-year | -26.6% | +41.2% | -31.1% | +505.1% | -31.8% | +41.9% |
alltime | all time | -26.6% | +1564.3% | -31.1% | +671.4% | -31.8% | >+9999.0% |
Abbott Laboratories Free cash flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | $6.35B(+25.5%) | $2.15B(-0.0%) | $6.35B(-2.1%) |
Sep 2024 | - | $2.15B(+50.6%) | $6.49B(+14.7%) |
Jun 2024 | - | $1.43B(+127.6%) | $5.65B(+14.8%) |
Mar 2024 | - | $627.00M(-72.5%) | $4.92B(-2.7%) |
Dec 2023 | $5.06B(-35.2%) | $2.28B(+73.3%) | $5.06B(+12.6%) |
Sep 2023 | - | $1.32B(+89.2%) | $4.49B(-18.1%) |
Jun 2023 | - | $696.00M(-8.8%) | $5.49B(-19.6%) |
Mar 2023 | - | $763.00M(-55.5%) | $6.82B(-12.6%) |
Dec 2022 | $7.80B(-9.8%) | $1.72B(-25.8%) | $7.80B(-8.6%) |
Sep 2022 | - | $2.31B(+13.9%) | $8.54B(+0.9%) |
Jun 2022 | - | $2.03B(+16.5%) | $8.47B(+3.9%) |
Mar 2022 | - | $1.74B(-28.9%) | $8.15B(-5.7%) |
Dec 2021 | $8.65B(+51.1%) | $2.45B(+9.5%) | $8.65B(-7.2%) |
Sep 2021 | - | $2.24B(+30.6%) | $9.31B(+7.8%) |
Jun 2021 | - | $1.72B(-23.4%) | $8.64B(+13.6%) |
Mar 2021 | - | $2.24B(-28.2%) | $7.61B(+32.9%) |
Dec 2020 | $5.72B(+27.3%) | $3.12B(+98.7%) | $5.72B(+24.8%) |
Sep 2020 | - | $1.57B(+130.9%) | $4.59B(+0.5%) |
Jun 2020 | - | $680.00M(+91.5%) | $4.56B(+2.0%) |
Mar 2020 | - | $355.00M(-82.1%) | $4.48B(-0.5%) |
Dec 2019 | $4.50B(-8.3%) | $1.98B(+28.1%) | $4.50B(+17.9%) |
Sep 2019 | - | $1.55B(+161.3%) | $3.81B(-6.9%) |
Jun 2019 | - | $592.00M(+57.0%) | $4.10B(-8.0%) |
Mar 2019 | - | $377.00M(-71.0%) | $4.45B(-9.3%) |
Dec 2018 | $4.91B(+10.6%) | $1.30B(-29.0%) | $4.91B(+0.1%) |
Sep 2018 | - | $1.83B(+93.3%) | $4.90B(+1.8%) |
Jun 2018 | - | $946.00M(+13.6%) | $4.82B(-3.0%) |
Mar 2018 | - | $833.00M(-35.7%) | $4.97B(+12.0%) |
Dec 2017 | $4.43B(+113.0%) | $1.29B(-25.7%) | $4.43B(+11.1%) |
Sep 2017 | - | $1.74B(+58.9%) | $3.99B(+26.5%) |
Jun 2017 | - | $1.10B(+262.9%) | $3.15B(+16.0%) |
Mar 2017 | - | $302.00M(-64.5%) | $2.72B(+30.6%) |
Dec 2016 | $2.08B(+12.2%) | $851.00M(-6.0%) | $2.08B(+15.0%) |
Sep 2016 | - | $905.00M(+36.7%) | $1.81B(+7.2%) |
Jun 2016 | - | $662.00M(-297.0%) | $1.69B(-3.6%) |
Mar 2016 | - | -$336.00M(-157.9%) | $1.75B(-5.5%) |
Dec 2015 | $1.86B(-28.6%) | $580.00M(-26.0%) | $1.86B(-16.7%) |
Sep 2015 | - | $784.00M(+8.1%) | $2.23B(-5.9%) |
Jun 2015 | - | $725.00M(-411.2%) | $2.37B(+3.6%) |
Mar 2015 | - | -$233.00M(-124.5%) | $2.28B(-12.1%) |
Dec 2014 | $2.60B(+19.2%) | $951.00M(+2.9%) | $2.60B(-12.5%) |
Sep 2014 | - | $924.00M(+43.9%) | $2.97B(+29.7%) |
Jun 2014 | - | $642.00M(+692.6%) | $2.29B(+10.4%) |
Mar 2014 | - | $81.00M(-93.9%) | $2.07B(-4.8%) |
Dec 2013 | $2.18B(-71.0%) | $1.32B(+439.6%) | $2.18B(+10.4%) |
Sep 2013 | - | $245.00M(-42.5%) | $1.97B(-58.2%) |
Jun 2013 | - | $426.00M(+129.0%) | $4.72B(-20.5%) |
Mar 2013 | - | $186.00M(-83.3%) | $5.93B(-21.1%) |
Dec 2012 | $7.52B(+0.5%) | $1.12B(-62.6%) | $7.52B(-0.1%) |
Sep 2012 | - | $2.99B(+82.1%) | $7.53B(+5.4%) |
Jun 2012 | - | $1.64B(-7.3%) | $7.14B(-6.4%) |
Mar 2012 | - | $1.77B(+57.2%) | $7.63B(+2.0%) |
Dec 2011 | $7.48B(-3.1%) | $1.13B(-56.7%) | $7.48B(-10.7%) |
Sep 2011 | - | $2.60B(+22.2%) | $8.38B(+3.2%) |
Jun 2011 | - | $2.13B(+31.5%) | $8.12B(+0.7%) |
Mar 2011 | - | $1.62B(-20.0%) | $8.06B(+4.4%) |
Dec 2010 | $7.72B(+24.8%) | $2.03B(-13.6%) | $7.72B(+6.0%) |
Sep 2010 | - | $2.34B(+12.9%) | $7.28B(-4.7%) |
Jun 2010 | - | $2.07B(+62.4%) | $7.64B(+8.9%) |
Mar 2010 | - | $1.28B(-19.5%) | $7.02B(+13.4%) |
Dec 2009 | $6.19B(+8.4%) | $1.59B(-41.2%) | $6.19B(+11.1%) |
Sep 2009 | - | $2.70B(+86.2%) | $5.57B(+6.2%) |
Jun 2009 | - | $1.45B(+224.9%) | $5.24B(+1.2%) |
Mar 2009 | - | $446.57M(-53.9%) | $5.18B(-9.2%) |
Dec 2008 | $5.71B(+61.8%) | $967.99M(-59.3%) | $5.71B(+6.5%) |
Sep 2008 | - | $2.38B(+71.4%) | $5.36B(+29.7%) |
Jun 2008 | - | $1.39B(+42.8%) | $4.13B(+9.5%) |
Mar 2008 | - | $972.17M(+56.5%) | $3.77B(+6.9%) |
Dec 2007 | $3.53B | $621.31M(-46.0%) | $3.53B(-9.1%) |
Sep 2007 | - | $1.15B(+11.8%) | $3.88B(+5.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2007 | - | $1.03B(+41.5%) | $3.66B(-4.4%) |
Mar 2007 | - | $727.17M(-25.4%) | $3.83B(-4.0%) |
Dec 2006 | $3.99B(+0.6%) | $974.42M(+4.5%) | $3.99B(-1.6%) |
Sep 2006 | - | $932.55M(-22.1%) | $4.06B(-5.4%) |
Jun 2006 | - | $1.20B(+35.0%) | $4.29B(-7.9%) |
Mar 2006 | - | $886.87M(-14.7%) | $4.65B(+17.3%) |
Dec 2005 | $3.97B(+24.9%) | $1.04B(-10.6%) | $3.97B(+15.6%) |
Sep 2005 | - | $1.16B(-25.7%) | $3.43B(+24.2%) |
Jun 2005 | - | $1.56B(+684.0%) | $2.76B(+15.9%) |
Mar 2005 | - | $199.58M(-60.4%) | $2.38B(-24.9%) |
Dec 2004 | $3.18B(+26.9%) | $503.77M(+2.0%) | $3.18B(+5.6%) |
Sep 2004 | - | $493.86M(-58.4%) | $3.01B(-7.9%) |
Jun 2004 | - | $1.19B(+19.6%) | $3.26B(+15.1%) |
Mar 2004 | - | $991.75M(+194.8%) | $2.84B(+13.3%) |
Dec 2003 | $2.50B(-13.3%) | $336.44M(-55.2%) | $2.50B(-16.0%) |
Sep 2003 | - | $750.62M(-1.0%) | $2.98B(+5.6%) |
Jun 2003 | - | $757.88M(+15.2%) | $2.82B(+4.2%) |
Mar 2003 | - | $658.10M(-19.1%) | $2.71B(-6.3%) |
Dec 2002 | $2.89B(+20.1%) | $813.33M(+37.5%) | $2.89B(+11.1%) |
Sep 2002 | - | $591.32M(-8.1%) | $2.60B(-6.6%) |
Jun 2002 | - | $643.29M(-23.3%) | $2.78B(+8.6%) |
Mar 2002 | - | $838.70M(+59.7%) | $2.56B(+6.5%) |
Dec 2001 | $2.40B(+16.4%) | $525.29M(-32.1%) | $2.40B(+2.5%) |
Sep 2001 | - | $774.16M(+83.5%) | $2.34B(+14.3%) |
Jun 2001 | - | $421.90M(-38.1%) | $2.05B(-21.3%) |
Mar 2001 | - | $681.79M(+46.1%) | $2.61B(+26.3%) |
Dec 2000 | $2.06B(+19.1%) | $466.55M(-2.9%) | $2.06B(+42.2%) |
Sep 2000 | - | $480.48M(-50.9%) | $1.45B(-14.7%) |
Jun 2000 | - | $978.55M(+608.3%) | $1.70B(+34.7%) |
Mar 2000 | - | $138.16M(-195.0%) | $1.26B(-27.1%) |
Dec 1999 | $1.73B(+12.7%) | -$145.42M(-119.9%) | $1.73B(-17.2%) |
Sep 1999 | - | $730.82M(+35.4%) | $2.09B(+112.0%) |
Jun 1999 | - | $539.77M(-11.3%) | $987.86M(-34.3%) |
Mar 1999 | - | $608.23M(+181.8%) | $1.50B(-2.3%) |
Dec 1998 | $1.54B(+6.0%) | $215.80M(-157.4%) | $1.54B(+2.9%) |
Sep 1998 | - | -$375.94M(-135.6%) | $1.49B(-16.2%) |
Jun 1998 | - | $1.05B(+64.0%) | $1.78B(+36.3%) |
Mar 1998 | - | $643.00M(+272.3%) | $1.31B(-9.8%) |
Dec 1997 | $1.45B(+1.2%) | $172.70M(-300.6%) | $1.45B(-8.3%) |
Sep 1997 | - | -$86.11M(-114.9%) | $1.58B(-24.0%) |
Jun 1997 | - | $579.28M(-26.2%) | $2.08B(+17.9%) |
Mar 1997 | - | $784.63M(+158.8%) | $1.76B(+23.0%) |
Dec 1996 | $1.43B(-27.1%) | $303.13M(-26.4%) | $1.43B(-7.0%) |
Sep 1996 | - | $411.87M(+56.2%) | $1.54B(-6.5%) |
Jun 1996 | - | $263.70M(-42.0%) | $1.65B(-13.8%) |
Mar 1996 | - | $454.40M(+10.5%) | $1.91B(-2.7%) |
Dec 1995 | $1.97B(-11.1%) | $411.18M(-20.8%) | $1.97B(-8.4%) |
Sep 1995 | - | $519.18M(-1.5%) | $2.15B(-3.6%) |
Jun 1995 | - | $526.89M(+3.7%) | $2.23B(+2.5%) |
Mar 1995 | - | $508.33M(-14.1%) | $2.17B(-1.7%) |
Dec 1994 | $2.21B(+19.8%) | $591.69M(-1.5%) | $2.21B(-20.7%) |
Sep 1994 | - | $600.46M(+26.9%) | $2.79B(+10.8%) |
Jun 1994 | - | $473.14M(-13.5%) | $2.52B(+16.0%) |
Mar 1994 | - | $546.85M(-53.2%) | $2.17B(+17.5%) |
Dec 1993 | $1.85B(+384.0%) | $1.17B(+255.8%) | $1.85B(+109.7%) |
Sep 1993 | - | $328.60M(+162.9%) | $880.80M(+54.3%) |
Jun 1993 | - | $125.00M(-44.2%) | $571.00M(+3.0%) |
Mar 1993 | - | $224.20M(+10.4%) | $554.30M(+45.3%) |
Dec 1992 | $381.60M(-44.1%) | $203.00M(+979.8%) | $381.60M(+18.5%) |
Sep 1992 | - | $18.80M(-82.6%) | $322.00M(-39.2%) |
Jun 1992 | - | $108.30M(+110.3%) | $530.00M(-17.6%) |
Mar 1992 | - | $51.50M(-64.1%) | $643.10M(-5.8%) |
Dec 1991 | $682.60M(+22.0%) | $143.40M(-36.8%) | $682.60M(-6.4%) |
Sep 1991 | - | $226.80M(+2.4%) | $729.00M(+1.5%) |
Jun 1991 | - | $221.40M(+143.3%) | $718.50M(+22.3%) |
Mar 1991 | - | $91.00M(-52.1%) | $587.70M(+5.0%) |
Dec 1990 | $559.50M(+44.6%) | $189.80M(-12.3%) | $559.50M(+51.3%) |
Sep 1990 | - | $216.30M(+138.7%) | $369.70M(+141.0%) |
Jun 1990 | - | $90.60M(+44.3%) | $153.40M(+144.3%) |
Mar 1990 | - | $62.80M | $62.80M |
Dec 1989 | $386.80M | - | - |
FAQ
- What is Abbott Laboratories annual free cash flow?
- What is the all time high annual FCF for Abbott Laboratories?
- What is Abbott Laboratories annual FCF year-on-year change?
- What is Abbott Laboratories quarterly free cash flow?
- What is the all time high quarterly FCF for Abbott Laboratories?
- What is Abbott Laboratories quarterly FCF year-on-year change?
- What is Abbott Laboratories TTM free cash flow?
- What is the all time high TTM FCF for Abbott Laboratories?
- What is Abbott Laboratories TTM FCF year-on-year change?
What is Abbott Laboratories annual free cash flow?
The current annual FCF of ABT is $6.35B
What is the all time high annual FCF for Abbott Laboratories?
Abbott Laboratories all-time high annual free cash flow is $8.65B
What is Abbott Laboratories annual FCF year-on-year change?
Over the past year, ABT annual free cash flow has changed by +$1.29B (+25.54%)
What is Abbott Laboratories quarterly free cash flow?
The current quarterly FCF of ABT is $2.15B
What is the all time high quarterly FCF for Abbott Laboratories?
Abbott Laboratories all-time high quarterly free cash flow is $3.12B
What is Abbott Laboratories quarterly FCF year-on-year change?
Over the past year, ABT quarterly free cash flow has changed by -$135.00M (-5.91%)
What is Abbott Laboratories TTM free cash flow?
The current TTM FCF of ABT is $6.35B
What is the all time high TTM FCF for Abbott Laboratories?
Abbott Laboratories all-time high TTM free cash flow is $9.31B
What is Abbott Laboratories TTM FCF year-on-year change?
Over the past year, ABT TTM free cash flow has changed by +$1.29B (+25.54%)